Actualités Targeted Genetics Corp - TGEND | Actions NASDAQ

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Encouraging Interim Results from a Phase I/II Trial of Targeted Genetics' tgAAC94 in Patients with Inflammatory Arthritis; Inte

Targeted Genetics Corporation (Nasdaq:TGEND) reported preliminary efficacy data from its ongoing Phase I/II trial of tgAAC94 in patients with...

Targeted Genetics Enhances Inflammatory Arthritis Product Development Platform

Targeted Genetics Corporation (Nasdaq:TGEND) reported new data from studies designed to enhance the company's ability to develop novel therapeutic...

Targeted Genetics and Collaborators Advance Key Technologies For AAV-Based Product Development

Company-Sponsored Research Featured as One Of "Top Five Abstracts" at the Presidential Symposium at the American Society of Gene Therapy...

Targeted Genetics Advances Its Manufacturing Leadership; Additional Manufacturing Capabilities Reported at Scientific Meeting

Targeted Genetics Corporation (Nasdaq:TGEND) is reporting new developments in its portfolio of AAV manufacturing capabilities at the American...

Targeted Genetics Presents Encouraging Interim Data From an Ongoing Phase I/II Trial of tgAAC94 in Patients with Inflammatory A

Preliminary Data Show Positive Trends toward Sustained Improvement in Signs and Symptoms of Disease ? Targeted Genetics Corporation...

Targeted Genetics Highlights Inflammatory Arthritis Program and Robust AAV Product Development Platform at the American Society

Presentations Include Preliminary Data from an Ongoing Phase I/II Trial of tgAAC94 in Patients with Inflammatory Arthritis and 13 Additional...

Targeted Genetics Announces One-for-Ten Reverse Stock Split

Targeted Genetics Corporation (Nasdaq:TGEN) today announced that it has effected a one-for-ten reverse split of its common stock. The reverse...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Targeted Genetics Corp (TGEND)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

TGEND Actualités

Encouraging Interim Results from a Phase I/II Trial of Targeted Genetics' tgAAC94 in Patients with Inflammatory Arthritis; Inte

Targeted Genetics Enhances Inflammatory Arthritis Product Development Platform

Targeted Genetics and Collaborators Advance Key Technologies For AAV-Based Product Development

Targeted Genetics Advances Its Manufacturing Leadership; Additional Manufacturing Capabilities Reported at Scientific Meeting

Targeted Genetics Presents Encouraging Interim Data From an Ongoing Phase I/II Trial of tgAAC94 in Patients with Inflammatory A

Targeted Genetics Highlights Inflammatory Arthritis Program and Robust AAV Product Development Platform at the American Society

Targeted Genetics Announces One-for-Ten Reverse Stock Split

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Targeted Genetics Corp (TGEND) Actualités

Targeted Genetics Corp (TGEND)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

TGEND Actualités

Encouraging Interim Results from a Phase I/II Trial of Targeted Genetics' tgAAC94 in Patients with Inflammatory Arthritis; Inte

Targeted Genetics Enhances Inflammatory Arthritis Product Development Platform

Targeted Genetics and Collaborators Advance Key Technologies For AAV-Based Product Development

Targeted Genetics Advances Its Manufacturing Leadership; Additional Manufacturing Capabilities Reported at Scientific Meeting

Targeted Genetics Presents Encouraging Interim Data From an Ongoing Phase I/II Trial of tgAAC94 in Patients with Inflammatory A

Targeted Genetics Highlights Inflammatory Arthritis Program and Robust AAV Product Development Platform at the American Society

Targeted Genetics Announces One-for-Ten Reverse Stock Split

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application